Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 28 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

Severe pneumonia-associated lung injury: gut-lung-immune-metabolic connections in the critically ill host environment-microecology, barrier function, and mechanical ventilation

  1. 1Gansu Provincial Maternity and Child Care Hospital
  2. 2Gansu Provincial Maternity and Child Care Hospital (Gansu Provincial Central Hospital)

Abstract

Severe pneumonia-associated lung injury is a major cause of acute respiratory failure, acute respiratory distress syndrome (ARDS), and death in critically ill patients. Its course is shaped within the critically ill host environment by pulmonary infection and tissue injury, systemic inflammation, circulatory and organ dysfunction, host reserve, and ICU treatment exposures, and may be accompanied by changes in gut microbiota, barrier integrity, and cellular immune metabolism. Thus, pulmonary, intestinal, circulatory, and metabolic changes should be viewed as interrelated processes occurring at different physiological levels rather than as a predefined linear pathway. Emerging studies suggest links among gut microbiota remodeling, barrier disruption, microbial or host-derived circulating signals, altered microbial metabolites, and immune-cell metabolic reprogramming. However, their biological significance varies. Some may represent parallel responses to severe infection and critical illness, whereas others may arise secondary to lung injury, hypoxia, hypoperfusion, or treatment exposure. Longitudinal human evidence remains insufficient to establish whether gut-derived signals achieve physiologically effective remote exposure and independently modify lung injury. Mechanical ventilation is essential for severe respiratory failure, and its direct mechanical contribution to ventilator-induced lung injury has a relatively clear physiological basis. In contrast, sedation, hemodynamic and splanchnic perfusion changes, oxygenation and ventilation status, antibiotics, and nutritional support are distinct concomitant exposures that may independently influence gastrointestinal function, microbiota, barrier integrity, and immune metabolism. Using the critically ill host response as the overarching framework, this review evaluates the temporality, directionality, and functional support of relationships among gut microbiota, barrier function, candidate remote signals, cellular immune metabolism, and ventilation-related exposures, and assesses whether current evidence supports biologically and clinically meaningful gut-lung-immune-metabolic interactions. It also discusses lung-protective ventilation, nutritional support, microbiota modulation, anti-inflammatory therapy, and barrier protection. Current evidence derives mainly from limited studies in severe pneumonia or pneumonia-associated ARDS, clinical evidence from other critically ill populations, and preclinical studies. Evidence that pulmonary and systemic critical illness responses affect the gut is stronger than evidence for an independent gut-to-lung effect. Future longitudinal multi-compartment studies, source tracing, multi-omics integration, and mechanism-oriented interventions are needed to clarify functional cross-compartment relationships and their incremental clinical value for risk stratification and targeted treatment.

Related

  1. Prophylactic non-invasive ventilation vs. oxygen support after planned extubation in critically ill obese patients: A systematic review and meta-analysis
    Sylvain Le Pape, Audrey de Jong, Rémi Coudroy +5
    Journal of Intensive MedicinePeer-reviewedCC BY-NC-NDFull textGeneral biologyHAL
  2. Long-Term Fertilisation Regimes, Crop Yield and Rhizosphere Microecology in a Wheat–Soybean Rotation System
    Jingyang Li, Qiuju Wang, Xinyu Li +7
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textPlant biologyEurope PMC
  3. CSF pharmacokinetics-pharmacodynamics of linezolid in critically brain injured patients, with or without central nervous system healthcare-associated infection. The PK-Pop-LCR Study: A Multicentre Pharmacokinetics and Pharmacodynamics Population Study
    Claire Dahyot-Fizelier, Alexia Chauzy, Kévin Chalard +17
    International Journal of Antimicrobial AgentsPeer-reviewedLicence not stated1 citedGeneral biologyInfectious diseaseHAL
  4. Reduced integrity in the frontal aslant tract's premotor connections is associated with dysfluency severity in stuttering
    Maëva Michon, Fabrice Hirsch, Ivana Didirková +6
    PNAS NexusPeer-reviewedCC BY-NC 4.0Full textNeuroscienceHAL
  5. An Assessment of Floral Visitor Diversity and Visitation Patterns Associated with Bauhinia variegata L. in a Semi-Urban South African Environment
    Usia Matsila, Mokgaetji Georginah Mokganya
    Plants (Basel, Switzerland)Peer-reviewedCC BYFull textPlant biologyEurope PMC
BibTeX
@article{cheng2026severe,
  title = {{Severe pneumonia-associated lung injury: gut-lung-immune-metabolic connections in the critically ill host environment-microecology, barrier function, and mechanical ventilation}},
  author = {Cheng Cheng and Xia ping Xiao and Lei Zhang and De Chen and Ling Lu and Ying Liu and Song Du},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1914644},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1914644/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Severe pneumonia-associated lung injury: gut-lung-immune-metabolic connections in the critically ill host environment-microecology, barrier function, and mechanical ventilation
AU  - Cheng Cheng
AU  - Xia ping Xiao
AU  - Lei Zhang
AU  - De Chen
AU  - Ling Lu
AU  - Ying Liu
AU  - Song Du
PY  - 2026
DA  - 2026/10/21
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1914644
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1914644/full
AB  - Severe pneumonia-associated lung injury is a major cause of acute respiratory failure, acute respiratory distress syndrome (ARDS), and death in critically ill patients. Its course is shaped within the critically ill host environment by pulmonary infection and tissue injury, systemic inflammation, circulatory and organ dysfunction, host reserve, and ICU treatment exposures, and may be accompanied by changes in gut microbiota, barrier integrity, and cellular immune metabolism. Thus, pulmonary, intestinal, circulatory, and metabolic changes should be viewed as interrelated processes occurring at different physiological levels rather than as a predefined linear pathway. Emerging studies suggest links among gut microbiota remodeling, barrier disruption, microbial or host-derived circulating signals, altered microbial metabolites, and immune-cell metabolic reprogramming. However, their biological significance varies. Some may represent parallel responses to severe infection and critical illness, whereas others may arise secondary to lung injury, hypoxia, hypoperfusion, or treatment exposure. Longitudinal human evidence remains insufficient to establish whether gut-derived signals achieve physiologically effective remote exposure and independently modify lung injury. Mechanical ventilation is essential for severe respiratory failure, and its direct mechanical contribution to ventilator-induced lung injury has a relatively clear physiological basis. In contrast, sedation, hemodynamic and splanchnic perfusion changes, oxygenation and ventilation status, antibiotics, and nutritional support are distinct concomitant exposures that may independently influence gastrointestinal function, microbiota, barrier integrity, and immune metabolism. Using the critically ill host response as the overarching framework, this review evaluates the temporality, directionality, and functional support of relationships among gut microbiota, barrier function, candidate remote signals, cellular immune metabolism, and ventilation-related exposures, and assesses whether current evidence supports biologically and clinically meaningful gut-lung-immune-metabolic interactions. It also discusses lung-protective ventilation, nutritional support, microbiota modulation, anti-inflammatory therapy, and barrier protection. Current evidence derives mainly from limited studies in severe pneumonia or pneumonia-associated ARDS, clinical evidence from other critically ill populations, and preclinical studies. Evidence that pulmonary and systemic critical illness responses affect the gut is stronger than evidence for an independent gut-to-lung effect. Future longitudinal multi-compartment studies, source tracing, multi-omics integration, and mechanism-oriented interventions are needed to clarify functional cross-compartment relationships and their incremental clinical value for risk stratification and targeted treatment.
SN  - 1664-3224
ER  -